These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 126005)

  • 21. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the electrophoretic mobility of thymus, spleen and lymph node cells in tumor-bearing mice during dynamic tumor growth].
    Grinevich IuA; Fil'chakov FV; Alekseev SB; Kuz'menko AP
    Tsitologiia; 1989 Feb; 31(2):209-14. PubMed ID: 2734850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T and B lymphocyte migration into syngeneic tumors.
    Elboim CM; Reinisch CL; Schlossman SF
    J Immunol; 1977 Mar; 118(3):1042-8. PubMed ID: 300384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K-cell cytotoxic activity in the spleen and lymph nodes of tumour-bearing mice.
    Calder EA; Irvine WJ; Ghaffer A
    Clin Exp Immunol; 1975 Feb; 19(2):393-7. PubMed ID: 1212806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Natural killer activity of the splenocytes in C3HA strain mice during 20-methylcholanthrene-induced carcinogenesis].
    Pogodina ON; Malygin AM; Goriunova LB; Fel' VIa
    Tsitologiia; 1989 Feb; 31(2):220-5. PubMed ID: 2734852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line.
    Yokoyama H; Nakanishi H; Kodera Y; Ikehara Y; Ohashi N; Ito Y; Koike M; Fujiwara M; Tatematsu M; Nakao A
    Clin Cancer Res; 2006 Jan; 12(2):361-8. PubMed ID: 16428473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional lymphadenectomy and tumor immunity.
    Pendergrast WJ; Soloway MS; Myers GH; Futrell JW
    Surg Gynecol Obstet; 1976 Mar; 142(3):385-90. PubMed ID: 1251321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
    Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
    Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DNA metabolism in the immunocompetent organs of C57BL mice in chemical carcinogenesis].
    Gudim-Levkovich KA
    Vopr Onkol; 1976; 22(1):68-72. PubMed ID: 1266122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of antitumor immunity by tumor cells treated with abrin.
    Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY
    Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
    Krueger JG; Segal RA; Moyer RC
    Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node reactivity to experimental bladder tumor in preimmunized animals as measured by two parameter flow cytometry.
    Collste LG; Kostyrka-Claps ML; Darzynkiewicz Z; Devonec M; Traganos F; Whitmore WF; Melamed MR
    Invest Urol; 1979 Nov; 17(3):191-4. PubMed ID: 500314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.